Lv et al. (2021) indicated that fluorofenidone has a therapeutic effect on ALI by alleviating the lung tissue structure and decreasing the levels of IL-1β, IL-6, and TNF-α in the BALF. This evidence concerns the gene TNF and acute respiratory distress syndrome.